Fig. 20 (abstract P232).
TRAEs reported in > 2 patients or any TRAE ≥ grade 3 reported in patients treated with BMS-986016 ± nivolumab
Fig. 20 (abstract P232). | Journal for ImmunoTherapy of Cancer
TRAEs reported in > 2 patients or any TRAE ≥ grade 3 reported in patients treated with BMS-986016 ± nivolumab